Technical Analysis for PASG - Passage Bio, Inc.

Grade Last Price % Change Price Change
F 19.43 -2.66% -0.53
PASG closed down 2.66 percent on Thursday, March 4, 2021, on approximately normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical PASG trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish 0.00%
Bearish Engulfing Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Earnings Movers Other 0.00%
Multiple of Ten Bearish Other 0.00%
200 DMA Resistance Bearish -2.66%
20 DMA Resistance Bearish -2.66%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.66%
Earnings Movers Other -2.66%
Older End-of-Day Signals for PASG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 6 hours ago
Fell Below 10 DMA about 6 hours ago
10 DMA Support about 6 hours ago
Down 3% about 6 hours ago
60 Minute Opening Range Breakdown about 8 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Organ Systems Rare Diseases Nervous System Disorders Central Nervous System Disorders Lipid Storage Disorders Monogenic Gm1 Medicine Products Rare Tadataka Yamada

Is PASG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 38.23
52 Week Low 8.09
Average Volume 452,256
200-Day Moving Average 20.61
50-Day Moving Average 23.02
20-Day Moving Average 20.17
10-Day Moving Average 19.11
Average True Range 1.75
ADX 14.43
+DI 24.62
-DI 18.79
Chandelier Exit (Long, 3 ATRs ) 18.01
Chandelier Exit (Short, 3 ATRs ) 22.18
Upper Bollinger Band 22.83
Lower Bollinger Band 17.51
Percent B (%b) 0.36
BandWidth 26.38
MACD Line -0.94
MACD Signal Line -1.06
MACD Histogram 0.1224
Fundamentals Value
Market Cap 884.74 Million
Num Shares 45.5 Million
EPS -99999.99
Price-to-Earnings (P/E) Ratio 0.00
Price-to-Sales 0.00
Price-to-Book 3.22
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.08
Resistance 3 (R3) 24.39 23.14 23.31
Resistance 2 (R2) 23.14 21.96 22.99 23.05
Resistance 1 (R1) 21.29 21.23 20.67 20.98 22.79
Pivot Point 20.04 20.04 19.73 19.89 20.04
Support 1 (S1) 18.19 18.86 17.57 17.88 16.07
Support 2 (S2) 16.94 18.13 16.79 15.81
Support 3 (S3) 15.09 16.94 15.56
Support 4 (S4) 14.78